Using differential display PCR, we have identified two novel transcripts that are induced as a prechondroblastic cell line, MLB 13 MYC clone 17, acquires markers of the osteoblast phenotype in response to BMP-2 treatment. The first gene encodes a novel kinase that, when stably expressed in MC3T3E1 cells, results in a dramatic attenuation of the program of osteoblast differentiation. The second gene encodes a new member of the WD40 repeat family of proteins that markedly accelerates the program of osteoblast differentiation when stably expressed in MC3T3E1 cells. The presence of 7 WD repeats and of a short amino terminal non-beta-propeller region, coupled with the absence of a carboxy terminal extension and of a putative transactivation domain, link this protein most closely to the beta-transducin subfamily. However, the lack of a coiled-coil structure in the N- terminal extension of BIG-3 (BMP-2 Induced Gene-3Kb), and its cytoplasmic location, support the hypothesis that this protein is not a beta-transducin homolog. The studies proposed will address the hypothesis that the effects of BIG-3 on osteoblast differentiation require other actions of BMPs, by examining the program of osteoblast differentiation in noggin-treated MC3T3-E1 cells stably transfected with BIG-3 or empty vector. To address whether BIG-3 is essential for osteoblast differentiation, BIG-3 protein synthesis, in untransfected MC3T3-E 1 cells, will be blocked using antisense RNA strategies. Inhibition of BIG-3 protein expression will be evaluated and the impact of this reduction in BIG-3 protein levels on the differentiation of MC3T3-E1 cells will be examined. Deletion analyses will be performed to address the hypothesis that the amino terminal, non-WD repeat sequences contribute both to subcellular location and to the function of BIG-3. Yeast two-hybrid analyses will be performed to isolate proteins that interact with BIG-3 and contribute to its effects on osteoblast differentiation. Transgenic mice overexpressing BIG-3 in early osteoblasts (Col1-BIG-3) will be generated to address the hypothesis that BIG-3 accelerates the program of osteoblast differentiation in vivo. Analyses will be performed to assess whether this is associated with a parallel increase in osteoclast activity or whether uncoupling of bone formation and bone resorption is observed in the Col1-BIG-3 mice. Studies in primary osteoblasts isolated from these mice will determine if the overexpression of BIG-3 accelerates the differentiation of primary osteoblasts and whether it has effects on the differentiation and number of """"""""osteoprogenitors"""""""" that give rise to endochondral and intramembranous bone.
Showing the most recent 10 out of 22 publications